Carisma Therapeutics has gone public, entered a broad collaboration with Moderna, and ceased development of its original ...

We live in a time of hope for millions around the world, as technological advancements and research breakthroughs hold the ...

Effective provider segmentation can make or break a new drug launch, and can also improve the lifecycle of existing portfolio ...

The brain cancer therapy recently approved by the FDA, Voranigo (vorasidenib), was developed from research by Duke University’s Darell Bigner and Johns Hopkins University's Bert Vogelstein and ...

We live in an era of extraordinary scientific advancement, and as a result, we are seeing rapid growth in the development of new drugs. When the clinical trial ecosystem works, we deliver on our ...

Conventional process liquid and buffer manufacturing is resource-intensive, requiring a significant facility footprint and high costs associated with labor, particularly as biologic drug production ...

The rapid adoption of AI in the pharmaceutical market has led to a revolution in the research process and pharmaceutical development techniques. The AI revolution is not free of risks, however. This ...

In August 2023, Gut, a journal published by BMJ, released a study of over 24,000 patients with Parkinson’s disease, finding that certain gastrointestinal disorders — such as difficulty swallowing, ...

The article emphasizes the importance of early engagement with regulatory agencies and collaborating with experienced authorities to streamline the review process and enhance market access. The ...

Google’s global market leader for life sciences, Shweta Maniar, spoke with Life Science Leader about how large and small biopharmaceutical companies are using AI to lower costs and expedite timelines.